A myeloid-derived suppressor cell-mediated T-cell suppression assay for functional evaluation of immune cells in tumor-bearing mice

Cold Spring Harbor Protocols

Volumn 2013, Issue 9, 2013, Pages 849-853

  Bayne, Lauren J ^a   Vonderheide, Robert H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; OVA 257 PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL SUSPENSION; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NEOPLASM; NONHUMAN; SPLEEN CELL; SUPPRESSOR CELL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; CELL PROLIFERATION; IMMUNOSUPPRESSION; MICE; MICE, TRANSGENIC; NEOPLASMS; OVALBUMIN; SPLEEN; T-LYMPHOCYTES;

EID: 84883470655     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.prot077214     Document Type: Article

References (1)

1. Bayne L. J, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH. 2012. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21: 822-835.